Skip to content
peptide

IGF-1 DES (1-3)

emergingResearch Use OnlyInjection

10x more potent IGF-1 variant with very short half-life. Inject directly into target muscle for localized growth before it clears.

Key facts
Classification
Peptide — 10x more potent IGF-1 variant with very short duration. Targets local muscle.
Primary benefits
Muscle Growth (9/10) · Injury Healing (4/10) · Fat Loss (3/10)
Administration
Injection
Doses studied
50-100 mcg subq directly into the target muscle right after your workout. Cycle for 4 weeks max.
Evidence strength
Emerging — 20 peer-reviewed studies
Stacks well with
IGF-1 LR3, PEG-MGF
Legal status
Research Use Only · not prescribable in US · WADA prohibited
Quick stats
Type
Peptide
Administration
Injection
Studies referenced
20
Stacks with
2 peptides
Regulatory
Research Use Only
Goal coverage · IGF-1 DES (1-3)
💪 Muscle Growth9/10
🩹 Injury Healing4/10
🔥 Fat Loss3/10
FIG.1  Modeled goal coverage from reviewed studies. Score out of 10.
From our network:Cornerstone Peptide